Abstract
The standard process for protein A purification using resin is labor-intensive, costly, and fraught with inefficiencies and bioburden risks that can put you over budget and lengthen your timeline to the clinical phase.
Join us and explore research around the future of protein A purification – a new fully single-use membrane technology for Protein A capture chromatography and explore how it is poised to change how antibody drug products are brought to market.
Speaker: Chase Snyder
Sr. Development Associate, AGC Biologics
Speaker: Bill Barrett
Global Product Specialist, Gore
